EpilepsyGTx

The startup develops gene therapy tools specifically designed to provide targeted treatments for epilepsy through precise genetic modifications. By addressing the underlying genetic causes of epilepsy, the company aims to improve patient outcomes and reduce the frequency of seizures.

Traction –/10

Cambridge, United Kingdom · HQ

2500+ followers

Biotechnology

Updated 5 months ago

Funding

Raised to date

$10MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Nicolas Koebel

CEO

Product

Features

The startup develops gene therapy tools specifically designed to provide targeted treatments for epilepsy through precise genetic modifications. By addressing the underlying genetic causes of epilepsy, the company aims to improve patient outcomes and reduce the frequency of seizures.